Halifax, NS – April 30, 2004 – MedMira says that its founder and chief operating officer, Hermes Chan, was this year’s recipient of the award for research excellence presented by BioNova, Nova Scotia’s biotechnology industry association.
Mr Chan is the inventor of MedMira’s advanced flow-through technology platform that is used as the basis for developing rapid diagnostic tests that provide fast results for a number of infectious and non-infectious diseases. Since its initial successes, this technology platform continues to allow MedMira to expand its product lines to include reliable rapid diagnostic tests for various infectious diseases and cancers.
MedMira says it has shipped over 500,000 of its rapid HIV-1 antibody tests to the US, where, according to market research, over 65 million HIV tests are conducted annually.
Have your say: